U.S. markets closed
  • S&P Futures

    3,705.00
    -4.00 (-0.11%)
     
  • Dow Futures

    29,660.00
    -9.00 (-0.03%)
     
  • Nasdaq Futures

    11,362.50
    -14.25 (-0.13%)
     
  • Russell 2000 Futures

    1,684.70
    -1.40 (-0.08%)
     
  • Crude Oil

    79.50
    +0.76 (+0.97%)
     
  • Gold

    1,651.50
    -4.10 (-0.25%)
     
  • Silver

    18.77
    -0.14 (-0.71%)
     
  • EUR/USD

    0.9686
    -0.0002 (-0.02%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • Vix

    29.92
    +2.57 (+9.40%)
     
  • GBP/USD

    1.0782
    -0.0075 (-0.69%)
     
  • USD/JPY

    143.5060
    +0.1860 (+0.13%)
     
  • BTC-USD

    18,766.87
    -154.27 (-0.82%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • Nikkei 225

    27,153.83
    -159.27 (-0.58%)
     

Why Bolt Biotherapeutics Stock Crashed Today

·2 min read
Why Bolt Biotherapeutics Stock Crashed Today

Shares of Bolt Biotherapeutics (NASDAQ: BOLT) crashed 55.8% on Monday. The steep decline came after the company presented interim data from a phase 1/2 study evaluating BDC-1001 at the European Society for Medical Oncology Immuno-Oncology (ESMO I-O) Congress that's being held virtually this week. Investors were clearly disappointed with Bolt's interim results.